Related Experiment Video

Updated: Jun 3, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Novel targeted therapies and vaccination strategies for mesothelioma

Mamta Bagia1, Anna K Nowak

  • 1NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia, mbagia@tpg.com.au.

Current Treatment Options in Oncology
|March 23, 2011
PubMed

Insights

Novel targeted therapies and cancer vaccines show promise but are not yet standard for malignant mesothelioma. Current standard care involves platinum and pemetrexed chemotherapy, with limited evidence for second-line treatments outside clinical trials.

Area of Science:

  • Oncology
  • Cancer Therapeutics
  • Malignant Mesothelioma Research

Background:

  • Novel targeted therapies are emerging in cancer treatment, but their optimal use, patient selection, and biomarkers require further study.
  • Cancer vaccination strategies have limited integration into routine oncological management.
  • Malignant mesothelioma treatment primarily relies on combination chemotherapy (platinum and pemetrexed) as first-line systemic therapy.

Purpose of the Study:

  • To review the current status and future potential of novel targeted therapies and cancer vaccinations in malignant mesothelioma treatment.
  • To evaluate the role of first- and second-line systemic therapies in malignant mesothelioma.
  • To determine the appropriate clinical settings for investigating new therapeutic approaches in this disease.

Main Methods:

  • Review of current literature on targeted therapies and cancer vaccines in oncology.
  • Analysis of established treatment guidelines for malignant mesothelioma.
  • Evaluation of evidence from clinical trials regarding second-line chemotherapy efficacy.

Main Results:

  • Targeted therapies and vaccinations are not currently standard treatments for malignant mesothelioma.
  • Platinum and pemetrexed combination chemotherapy is the established first-line standard.
  • The benefit of second-line chemotherapy in malignant mesothelioma remains uncertain due to a lack of controlled trials.

Conclusions:

  • Malignant mesothelioma management should adhere to established chemotherapy standards.
  • Novel targeted therapies and vaccinations should be investigated exclusively within clinical trials for this disease.
  • Further research is needed to define the role of advanced therapies in malignant mesothelioma.

More Related Videos

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...